About
Basic Data Updated:
12 days agoThe manufacturing of APIs and pharmaceutical intermediates is carried out by Arch Pharmalabs Limited. The company's wide range of products includes side chains of isoxazole penicillin, APIs for atorvastatin, clopidogrel, and gemcitabine. Currently, APL is operating 11 manufacturing units across the country, including two facilities owned by its subsidiary Avon Organics Ltd. (AOL). Out of these, three units have been approved by the US FDA, with one of them being owned by AOL. Additionally, one of the USFDA approved units has also received approvals from EDQM, TGA-Australia, and PMDA-Japan. These state-of-the-art facilities enable the company to supply its products in regulated markets upon registration and approval from the relevant authorities. Arch Pharmalabs Limited caters to both international and domestic pharmaceutical companies. The company was incorporated in 1993 and its registered office is located in Mumbai, Maharashtra.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231MH1993PLC150891 |
| Company No. | 150891 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 02 Apr 1993 |
| Date of AGM | 29 Dec 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Products or Services related to Arch Pharmalabs Limited
Anti Cancer Medicines
Anti Cancer Injection
Injectable Products
Anti Inflammatory Drugs
Financials of Arch Pharmalabs Limited
Arch Pharmalabs Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 19.31% increase. The company also saw a substantial improvement in profitability, with a 1265.7% increase in profit. The company's net worth Soared by an impressive increase of 112.7%.
Corporate Structure
Unlock access to Arch Pharmalabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Arch Pharmalabs Limited
Unlock and access historical data on people associated with Arch Pharmalabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Ajit Kamath
Managing DirectorAppointment Date: 01-Nov-2003
Status: Current
RK
Rajendra Kaimal CFOAppointment Date: 30-May-2019
Status: Current
VK
Vikas Kedia Company SecretaryAppointment Date: 18-Nov-2017
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2022 | ₹32.00 Cr | Open |
Others Creation Date: 20 Jul 2021 | ₹0.50 M | Open |
Others Creation Date: 27 May 2021 | ₹200.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arch Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Pharmalabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Arch Life Sciences Limited
Active
20 years 5 months Ajit Kamath and Rajendra Kaimal are mutual person
Kobo Biotech Limited
Active 30 years 9 months Ajit Kamath, Rajendra Kaimal and 1 more are mutual person
Vitalife Pharma Limited
Active 3 years 2 months Ashish Ujagare, Ajit Kamath and 1 more are mutual person
Arch Agro Industries Private Limited
Active 12 years 11 months Ajit Kamath and Rajendra Kaimal are mutual person
Recent activity within the organization
Annual General Meeting
Arch Pharmalabs Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records.
29 Dec 2023Balance Sheet
Arch Pharmalabs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge with Others amounted to Rs. 32.00 cr with Charge ID 100571158 was registered on 29 Mar 2022.
29 Mar 2022Charges
A charge with Others amounted to Rs. 0.05 cr with Charge ID 100463954 was registered on 20 Jul 2021.
20 Jul 2021Charges
A charge with Others amounted to Rs. 200.00 cr with Charge ID 100464383 was registered on 27 May 2021.
27 May 2021
Recent News, Updates & Announcement
Neuland Laboratories acquires Arch Pharma Labs.4-Traders 13 Dec 2017
- Neuland Labs buys API plant under SARFAESI Act for undisclosed amount .
Moneycontrol 22 Nov 2017
- Intrexon and Arch Pharmalabs Collaborate on Fermentative Production of an API to Replace Existing Process Sourced from Animals.
PRNewswire Intrexon Corporation NYSE XON a leader in the engineering and industrialization of biology to improve the quality of life and health of the.
PR Newswire 23 Oct 2017
- CDR failure rate points to limitations of approach Mint.
RBIs corporate debt restructuring cells failure rate in servicing bad loans in the banking sector was 43 until June against 36 a year ago.
mint 15 Sep 2016
Frequently asked questions
What is the Incorporation or founding date of Arch Pharmalabs Limited?
